相似文献
1
Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin.
Crit Care. 2008;12(2):414. doi: 10.1186/cc6843. Epub 2008 Apr 9.
2
Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient.
J Mycol Med. 2018 Mar;28(1):218-221. doi: 10.1016/j.mycmed.2017.09.003. Epub 2017 Nov 11.
3
Kodamaea ohmeri fungaemia successfully treated with caspofungin.
Int J Antimicrob Agents. 2010 Jan;35(1):98-9. doi: 10.1016/j.ijantimicag.2009.09.010. Epub 2009 Nov 5.
4
Seven cases of Saccharomyces fungaemia related to use of probiotics.
Mycoses. 2017 Jun;60(6):375-380. doi: 10.1111/myc.12604. Epub 2017 Jan 30.
5
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Med Mycol. 2005 Dec;43(8):731-4. doi: 10.1080/13693780500302593.
6
Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
Diagn Microbiol Infect Dis. 2017 Mar;87(3):286-288. doi: 10.1016/j.diagmicrobio.2016.12.004. Epub 2016 Dec 16.
7
Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum.
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):143-6. doi: 10.1177/039463201402700120.
8
[Saccharomyces boulardii fungal sepsis: beware of the yeast].
Can J Anaesth. 2007 Mar;54(3):245-6. doi: 10.1007/BF03022650.
9
Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
Infect Dis Now. 2021 May;51(3):293-295. doi: 10.1016/j.idnow.2020.12.003. Epub 2020 Dec 31.
10
Invasive infections due to Saccharomyces boulardii (Ultra-levure).
Prescrire Int. 2007 Jun;16(89):110.
引用本文的文献
1
Antibiotic Resistance Gene Expression in Veterinary Probiotics: Two Sides of the Coin.
Vet Sci. 2025 Mar 2;12(3):217. doi: 10.3390/vetsci12030217.
2
Comprehensive Metagenomic Analysis of Veterinary Probiotics in Broiler Chickens.
Animals (Basel). 2024 Jun 29;14(13):1927. doi: 10.3390/ani14131927.
3
Pediococcus pentosaceus Endocarditis in a Patient With Recent Transcatheter Aortic Valve Implantation and Liver Cirrhosis: A Case Report and Review of the Literature.
Cureus. 2024 Apr 3;16(4):e57509. doi: 10.7759/cureus.57509. eCollection 2024 Apr.
4
Antibiofilm Effect of Curcumin on during Beer Fermentation and Bottle Aging.
Biomolecules. 2023 Sep 8;13(9):1367. doi: 10.3390/biom13091367.
5
A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin.
BMC Infect Dis. 2023 May 16;23(1):329. doi: 10.1186/s12879-023-08287-9.
6
Impact of Intensive Care Unit Nutrition on the Microbiome and Patient Outcomes.
Anesthesiol Clin. 2023 Mar;41(1):263-281. doi: 10.1016/j.anclin.2022.10.007.
7
Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients.
Front Nutr. 2022 Oct 20;9:993668. doi: 10.3389/fnut.2022.993668. eCollection 2022.
8
Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation.
Cancers (Basel). 2021 Sep 17;13(18):4665. doi: 10.3390/cancers13184665.
9
Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements.
Emerg Infect Dis. 2021 Aug;27(8):2090-6. doi: 10.3201/eid2708.210018.
10
Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis.
Cancers (Basel). 2020 May 22;12(5):1326. doi: 10.3390/cancers12051326.
本文引用的文献
1
Review article: yeast as probiotics -- Saccharomyces boulardii.
Aliment Pharmacol Ther. 2007 Sep 15;26(6):767-78. doi: 10.1111/j.1365-2036.2007.03442.x.
2
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients.
Intensive Care Med. 2002 Jun;28(6):797-801. doi: 10.1007/s00134-002-1267-9. Epub 2002 May 10.
3
Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii.
Am J Med. 1998 Jul;105(1):71-2. doi: 10.1016/s0002-9343(98)00133-8.
4
Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial.
Intensive Care Med. 1997 May;23(5):517-23. doi: 10.1007/s001340050367.
Zotero 插件